Influenza A, M-Protein Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Influenza A, M-Protein antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Influenza A, M-Protein |
| Clone | polyclonal |
| Host Species | Mouse (Balb/c) |
| Reactive Species | n/a |
| Isotype | n/a |
| Format | unconjugated |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | ELISA - Quality tested. Immunocytochemistry (ICC). Western Blot (WB) - Reported in literature |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Influenza virus type A matrix protein. Influenza virus type A matrix protein, also known as M1, is composed of a 252 amino acid sequence and is type-specific in influenza viruses.1 It is located inside the viral lipid envelope and plays a key role in virus assembly and replication.2 M1 can be isolated from particles by removing the envelope with detergents and reducing the pH to 4.0.3 The monoclonal antibody FluAc has been shown to specifically recognize type A influenza virus M1 in virus infected cell culture. |
| Immunogen | Immunogen: Recombinant influenza virus type A matrix protein. Handling: The purified (UNLB) antibody is supplied as 0.1 mg of purified immunoglobulin in 0.2 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added. |
| Other Names | n/a |
| Gene, Accession # | n/a |
| Catalog # | MBS670268 |
| Price | $220 |
| Order / More Info | Influenza A, M-Protein Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Winter, G., and S. Fields. 1980. Nucleic Acids Res. 8:1965.2. Skehel, J.J., and D.C. Wiley. 1995. Am. J. Respir. Crit. Care Med. 152:S13.3. Zhirnoz, O.P. 1992. Virology 186:324. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies